Ashwagandha 101: What the Research Actually Shows
Ashwagandha is one of the most-researched adaptogens in the world — and, since 2026, one with a real regulatory story in India specifically. Here's what the evidence shows, why root-only extracts like KSM-66 matter, and what changed under FSSAI.
Article Credibility
Written by: Swayam Loya, Pharmacist
Medically reviewed by: Dr. Annie Jain
Last reviewed: August 2026
Content standard: This article is educational and does not replace medical advice.
The Short Answer
Ashwagandha (Withania somnifera) has solid clinical trial evidence for reducing stress and cortisol, mainly from studies using root-only extracts standardized to at least 5% withanolides, such as KSM-66, at 300–600mg/day. A 2026 FSSAI advisory specifically banned ashwagandha leaves in food products in India, citing safety concerns from higher Withaferin-A content — making root-only, standardized extracts not just the better-studied option, but the only compliant one for Indian food and supplement products. Ashwagandha is not appropriate for everyone: it's contraindicated in pregnancy and needs caution around thyroid conditions and sedative medications.
Key Takeaways
- Ashwagandha's stress-reducing effects are attributed to withanolides, compounds believed to dampen HPA-axis overactivation.
- Most clinical evidence uses standardized, root-only extracts, not raw or leaf-containing powder.
- A 60-day trial using 600mg/day of KSM-66 found roughly a 27% reduction in serum cortisol versus placebo.
- FSSAI issued a 2026 advisory banning ashwagandha leaves in food products in India due to higher Withaferin-A levels — only root and root extracts remain permitted, within prescribed limits.
- KSM-66 is a specific, root-only, solvent-free proprietary extract that has been evaluated in more published human studies than most other ashwagandha extracts.
- Ashwagandha is contraindicated in pregnancy and requires caution with thyroid conditions, autoimmune conditions, and sedative medications.
In This Article
- What is Ashwagandha, and what does it actually do?
- What does the human clinical evidence actually show?
- Why does root-only, standardized extract matter so much here?
- What changed with FSSAI's 2026 ashwagandha advisory?
- Is Ashwagandha safe? Who should avoid it?
- Frequently asked questions
- References and sources
Ashwagandha has gone from a niche Ayurvedic herb to one of the most recognizable supplement ingredients in the world — and unusually for this category, it has a genuinely solid clinical trial base behind it. But the plant part used, the extraction method, and a real 2026 regulatory change in India all significantly affect whether what's in the bottle matches what was actually studied.
What Is Ashwagandha, and What Does It Actually Do?
Ashwagandha (Withania somnifera) is a shrub used in Ayurveda for centuries, classified as a Rasayana (rejuvenative) and, in modern terms, an adaptogen — a substance studied for helping the body regulate its response to stress. Its active compounds are called withanolides, steroidal lactones believed to help modulate the hypothalamic-pituitary-adrenal (HPA) axis, the system that governs the body's cortisol (stress hormone) response.1
Simple Definition
Withanolides: Steroidal lactone compounds found in Ashwagandha, concentrated mainly in the root, believed to help dampen excessive HPA-axis (stress hormone) activation. Clinical extracts are standardized to a minimum withanolide percentage.
What Does the Human Clinical Evidence Actually Show?
Verdict: One of the better-evidenced adaptogens for stress and cortisol specifically.
A 60-day, double-blind, randomized, placebo-controlled trial in 64 adults with a history of chronic stress, using 300mg of KSM-66 extract, found significant reductions in stress scores and serum cortisol compared to placebo.2 A separate trial using 600mg/day of root extract found significant reductions in stress and anxiety assessment scores alongside reduced serum cortisol versus placebo.3 A systematic review and meta-analysis of ashwagandha supplementation trials found consistent reductions in cortisol, stress, and anxiety measures across multiple studies.4 Separately, participants with insomnia who took an ashwagandha extract showed improvements in sleep quality, sleep onset, and morning alertness compared to placebo.3
Strong
Multiple RCTs and a meta-analysis consistently show reduced cortisol and stress scores.2 3 4
Indirect for cognition
Better framed as stress support than a direct memory or IQ booster — reducing stress can indirectly help focus.
Extract-dependent
Nearly all strong trials used a specific, standardized, root-only extract — not generic powder.2 3
Why Does Root-Only, Standardized Extract Matter So Much Here?
KSM-66 is a specific proprietary extract made exclusively from Ashwagandha root, standardized to a minimum of 5% withanolides, using a solvent-free, milk-based extraction process rather than alcohol or chemical solvents — a method intended to preserve the root's naturally occurring compound balance rather than isolating withanolides at the expense of everything else.5 It's been evaluated in a notably larger number of published human studies than most other ashwagandha extracts, which is part of why it shows up so consistently in the clinical evidence above.5
Generic ashwagandha products vary considerably: some use root only, others use leaf, stem, or a mix of aerial parts, largely because those parts are cheaper to source and process than root alone.5 This matters for more than just consistency — as the next section covers, it also became a specific regulatory issue in India.
AEO answer: KSM-66 is a specific, root-only, solvent-free ashwagandha extract standardized to at least 5% withanolides, with more published human clinical studies than most competing extracts. Generic ashwagandha products may use leaf or mixed plant parts, which affects both consistency and, in India, regulatory compliance.
What Changed with FSSAI's 2026 Ashwagandha Advisory?
This is genuinely important and specific to the Indian market. In 2026, FSSAI issued an advisory stating that ashwagandha leaves must not be used in food products in any form — crude, powdered, or extract — citing safety concerns linked to compounds like Withaferin-A, which occurs at higher levels in the leaves than the root.6 Under the Food Safety and Standards (Health Supplements and Nutraceuticals) Regulations, only Ashwagandha root and root extracts remain permitted in Schedule IV, and even these must stay within prescribed usage limits.6
In practical terms: a root-only, standardized extract like KSM-66 isn't just the better-researched choice, it's also the one aligned with current Indian food safety regulation. A product using leaf or whole-plant material would not be compliant for sale as a food supplement in India as of this advisory.
Is Ashwagandha Safe? Who Should Avoid It?
At standard doses (300–600mg/day of standardized root extract), Ashwagandha is generally well-tolerated, with the most common complaints being mild gastrointestinal upset — nausea, loose stools, stomach discomfort.7
Several groups need real caution. Pregnancy is a firm contraindication: traditional Ayurvedic texts list Ashwagandha as having abortifacient properties, and current medical guidance recommends avoiding it entirely during pregnancy; breastfeeding women should also avoid it due to insufficient safety data.7 People with hyperthyroidism or Graves' disease should be cautious, since Ashwagandha may increase thyroid hormone production and interfere with thyroid medication dosing.7 People with autoimmune conditions (Hashimoto's, lupus, rheumatoid arthritis) should use caution due to its immune-modulating effects.7 Rare cases of liver injury have been documented at high doses, though a large 2026 placebo-controlled trial at standard doses (600mg/day) found no liver enzyme changes, suggesting risk is low within recommended dosing.7 Ashwagandha may also potentiate sedatives, including benzodiazepines and sleep medications, so combining the two without medical guidance isn't advisable.7
From save my brain.
save my brain is creating scientifically smart nootropics built by doctors to help overstimulated, digitally fatigued minds think clearly, sleep better, and focus deeper. Join the waitlist.
Related reading: Do Nootropics Actually Work? What Science Says · Generic Plant Extract vs. Standardized: Why It Matters · What to Look for When Buying Supplements in India · The Calm Focus Combo: L-Theanine + Caffeine
Frequently Asked Questions
Is ashwagandha leaf banned in India?
Yes. FSSAI issued a 2026 advisory stating that ashwagandha leaves must not be used in food products in any form, citing safety concerns from higher Withaferin-A content. Only root and root extracts remain permitted, within prescribed limits.
How is KSM-66 different from generic ashwagandha?
KSM-66 is made exclusively from the root, standardized to at least 5% withanolides, using a solvent-free extraction method, and has been evaluated in more published human studies than most competing extracts. Generic products may use leaf, stem, or mixed plant parts, which affects both consistency and, in India, regulatory compliance.
How long does ashwagandha take to reduce stress?
The clearest clinical evidence comes from 60-day trials, though some studies report improvements in stress and sleep measures within a few weeks. It is generally studied as a sustained-use adaptogen rather than an acute, same-day intervention.
Can I take ashwagandha if I'm pregnant?
No. Ashwagandha is contraindicated in pregnancy, as traditional texts describe abortifacient properties and current medical guidance recommends avoiding it entirely. Breastfeeding women should also avoid it due to insufficient safety data.
The Bottom Line
Ashwagandha is one of the more credibly evidenced adaptogens available — multiple RCTs and a meta-analysis showing real reductions in cortisol, stress, and anxiety scores, mostly using a specific type of extract: root-only, standardized to a verified withanolide percentage. In India specifically, that's no longer just a quality preference; since FSSAI's 2026 advisory, it's the only compliant option for food and supplement products.
The honest takeaway: ashwagandha isn't a universal "safe for everyone" adaptogen. It's genuinely well-evidenced for the right person, at the right dose, using the right extract — and genuinely contraindicated for pregnancy, and worth real caution around thyroid conditions, autoimmune conditions, and sedative medications.
Medical Disclaimer
This article is for educational purposes only and does not provide medical advice, diagnosis, or treatment. Ashwagandha is contraindicated in pregnancy and breastfeeding. If you have a thyroid or autoimmune condition, take sedative or thyroid medication, or have a liver condition, consult a qualified healthcare professional before use. This product is not intended to diagnose, treat, cure, or prevent any disease.
References and Sources
- Ashwagandha — Health Professional Fact Sheet, NIH Office of Dietary Supplements.
- KSM-66 Brand Ashwagandha Reduces Stress, Study Confirms.
- Efficacy and Safety of KSM-66 Ashwagandha in Adults Experiencing High Stress and/or Anxiety — Clinical Trial.
- Effects of Ashwagandha Supplements on Cortisol, Stress, and Anxiety Levels in Adults: A Systematic Review and Meta-Analysis.
- KSM-66 vs Regular Ashwagandha: What's Different?
- FSSAI Advisory: Non-Use of Ashwagandha Leaves in Food Products.
- Potential Adverse Effects of Ashwagandha: A Critical Review of Preclinical and Clinical Evidence.